Ironwood Pharmaceuticals (IRWD) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Q3 2025 value amounting to -$2.21.
- Ironwood Pharmaceuticals' Debt to Equity fell 7222.39% to -$2.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.21, marking a year-over-year decrease of 7222.39%. This contributed to the annual value of -$1.28 for FY2024, which is 1143.35% up from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Debt to Equity of -$2.21 as of Q3 2025, which was down 7222.39% from -$1.9 recorded in Q2 2025.
- Ironwood Pharmaceuticals' 5-year Debt to Equity high stood at $0.23 for Q1 2022, and its period low was -$2.21 during Q3 2025.
- In the last 5 years, Ironwood Pharmaceuticals' Debt to Equity had a median value of -$1.3 in 2024 and averaged -$1.04.
- Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 2353.46% in 2024, then crashed by 7222.39% in 2025.
- Ironwood Pharmaceuticals' Debt to Equity (Quarter) stood at $0.19 in 2021, then increased by 20.75% to $0.23 in 2022, then crashed by 719.46% to -$1.44 in 2023, then increased by 11.43% to -$1.28 in 2024, then tumbled by 73.19% to -$2.21 in 2025.
- Its last three reported values are -$2.21 in Q3 2025, -$1.9 for Q2 2025, and -$1.15 during Q1 2025.